Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you about the following forthcoming Analyst Meetings: i) Con-call with the representative(s) of Sundaram Asset Management Company Limited, at 10.30 A.M. on Monday, September 30, 2019. ii) Meeting with the representative(s) of Fundsmith LLP, at 02.30 P.M. on Tuesday, October 01, 2019 at the Corporate Office of the Company. Please note that these are subject to any last minute changes
26-09-2019
Bigul

Thyrocare Technologies Ltd - 539871 - Outcome of Board Meeting

 The Board of Directors met today to discuss about the offer of Dr. A. Velumani, Chairman, Managing Director & CEO to acquire the shareholding of Nueclear Healthcare Limited, the wholly owned subsidiary.The Audit Committee, which discussed the matter prior to the Board Meeting, had reviewed the valuation reports received from Karvy Investor Services Ltd. and noted the long gestation period of this business in terms of returns. The Committee also felt that accepting the offer of Dr. A. Velumani may result in dilution of his focus and time, which is not in the interest of the Company. In view of the above, the Audit Committee had recommended that it is not expedient to accept the offer of Dr. A. Velumani at this juncture. The Board accepted the above recommendation of the Audit Committee. Dr. A. Velumani,Mr. A.Sundararaju and Miss.Amruta Velumani, the promoter-directors, were not present during the discussions at the Audit Committee Meeting and at the meeting of the Board of Directors.
21-09-2019
Bigul

Thyrocare Technologies Ltd - 539871 - Board Meeting Intimation for To Consider Valuation Report Of NHL, Wholly Owned Subsidiary Company

 Thyrocare Technologies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/09/2019 ,inter alia, to consider and approve This is to inform you that a meeting of the Board of Directors will be held on Saturday, the 21st September 2019, to consider the report of valuation of the wholly owned subsidiary company, Nueclear Healthcare Limited (NHL), obtained from a second valuer engaged for the purpose, in the context of deciding whether to retain the Company's shareholding in NHL or dispose it of.
19-09-2019
Bigul

Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 --o-- Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you about the following forthcoming Analyst Meetings: i) Meeting with the representative(s) of Sunidhi Securities & Finance Limited, at 04.00 P.M. on Thursday, September 19, 2019 at the Corporate Office of the Company. ii) Meeting with the representative(s) of India Ratings & Research (Fitch Group), at 04.00 P.M. on Friday, September 20, 2019 at the Corporate Office of the Company. Please note that these are subject to any last minute changes
18-09-2019
Bigul

Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the representative(s) of Angel Broking Limited would be having a Con-call with us by 11.00 A.M. on Monday, September 16, 2019. Please note that this is subject to any last minute changes.
11-09-2019
Bigul

Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the representative(s) of SAIF Partners would be having a meeting with us at 10.30 A.M. on Tuesday, August 27, 2019 at the Corporate Office of the Company. Please note that this is subject to any last minute changes.
26-08-2019
Bigul

Thyrocare Technologies Ltd - 539871 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)

 Thyrocare Technologies Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here
26-08-2019
Bigul

Thyrocare Technologies Ltd - 539871 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

 As already reported, the 19th Annual General Meeting ('AGM') of the Company was held on August 24, 2019 at 3.00 p.m. at Hotel Yogi Midtown, Plot No. DX-12, TTC Industrial Area, Mumbai-Pune Road, Turbhe, Navi Mumbai - 400705. In this regard, please find enclosed the following: 1. Voting results in the specified format, as required under Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015; 2. Report of Scrutinizer dated August 25, 2019, pursuant to Section 108 of Companies Act, 2013 ('Act'), Rule 20 (4) (xii) of the Companies (Management and Administration) Rules 2014; The above details are uploaded on the Company's website (www.thyrocare.com). Kindly take the same on your record.
26-08-2019
Bigul

Thyrocare Technologies Ltd - 539871 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

 As already reported, the 19th Annual General Meeting ('AGM') of the Company was held on August 24, 2019 at 3.00 p.m. at Hotel Yogi Midtown, Plot No. DX-12, TTC Industrial Area, Mumbai-Pune Road, Turbhe, Navi Mumbai - 400705. In this regard, please find enclosed the following: 1. Voting results in the specified format, as required under Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015; 2. Report of Scrutinizer dated August 25, 2019, pursuant to Section 108 of Companies Act, 2013 ('Act'), Rule 20 (4) (xii) of the Companies (Management and Administration) Rules 2014; The above details are uploaded on the Company's website (www.thyrocare.com). Kindly take the same on your record.
26-08-2019
Bigul

Thyrocare Technologies Ltd - 539871 - Shareholder Meeting / Postal Ballot-Outcome of AGM

 In continuation to our letter dated July 31, 2019, we wish to inform you that the 19th Annual General Meeting ('AGM') of the Company was held today, August 24, 2019, and all the items of business mentioned in the Notice dated May 18, 2019 , were transacted. In this regard, please find enclosed the Summary of proceedings as required under Regulation 30, Part-A of Schedule -III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This is for your information and records.
24-08-2019
Next Page
Close

Let's Open Free Demat Account